JPH0423968A - Composition for food - Google Patents

Composition for food

Info

Publication number
JPH0423968A
JPH0423968A JP2125544A JP12554490A JPH0423968A JP H0423968 A JPH0423968 A JP H0423968A JP 2125544 A JP2125544 A JP 2125544A JP 12554490 A JP12554490 A JP 12554490A JP H0423968 A JPH0423968 A JP H0423968A
Authority
JP
Japan
Prior art keywords
calcium
water
dietary fiber
food composition
soluble dietary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2125544A
Other languages
Japanese (ja)
Other versions
JP2673992B2 (en
Inventor
Tokutsugu Ota
太田 篤胤
Yoshimi Oohashi
大橋 愛美
Masahiko Yamada
昌彦 山田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Priority to JP2125544A priority Critical patent/JP2673992B2/en
Publication of JPH0423968A publication Critical patent/JPH0423968A/en
Application granted granted Critical
Publication of JP2673992B2 publication Critical patent/JP2673992B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)

Abstract

PURPOSE:To obtain a composition for foods effectively suppressing appetite and having improved glucose tolerance, by adding an insoluble calcium compound to water-soluble food fibers in a neutral range. CONSTITUTION:A composition for foods, comprising water-soluble food fibers such as alginic acid or a salt thereof and one or more calcium compounds insoluble in a neutral range selected from a group consisting of calcium carbonate, potassium tertiary phosphate, eggshell calcium, bovine bone calcium and fish bone calcium in a ratio to make the blend gelatinous in contact of the water-soluble food fibers and an aqueous solution the calcium compound with gastric juice, for example, a weight ratio of the water-soluble food fibers and calcium in the calcium compound of (1:0:1)-(1:10).

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、食品用組成物に関する。本廃明の食品用組成
物は、空腹感を軽減し、摂食量を減少させることを目的
とするもので、たとえば肥満の予防および治療時の減食
療法などのほか、飲食後栄養素の吸収を遅延させて血液
成分の急激な変化を避け、結果として耐糖能を改善しイ
ンスリンの分泌を抑制する目的で糖尿病患者なと耐糖能
の低下している者および耐糖能の低下を予防したい者の
食事に配合し使用される。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a food composition. This food composition is aimed at alleviating hunger and reducing the amount of food intake, and can be used, for example, in diet reduction therapy during the prevention and treatment of obesity, as well as by delaying the absorption of nutrients after eating and drinking. In order to avoid sudden changes in blood components, and as a result improve glucose tolerance and suppress insulin secretion, it is recommended for use in the diet of diabetic patients, people with decreased glucose tolerance, and those who want to prevent decreased glucose tolerance. It is mixed and used.

〔従来の技術および発明が解決しようとする課題〕飽食
の時代と言われる今日、肥満症の増加は重大な社会問題
となりつつある。疫学的な調査からも肥満者では、糖尿
病、高血圧、心臓病なとの成人病の発生率が高いことな
ども報告されている。
[Problems to be solved by conventional techniques and inventions] In today's era, which is said to be an age of satiation, the increase in obesity is becoming a serious social problem. Epidemiological studies have also reported that obese people have a higher incidence of adult diseases such as diabetes, hypertension, and heart disease.

肥満症の大部分は摂取カロリーの過剰に起因している。Most obesity is caused by excessive calorie intake.

従って、その予防や治療の基本は、摂取カロリーを低減
すること、すなわち減食療法を実施することである。減
食療法の実施における最大の障害は強い空腹感のために
継続が困難となることである。空腹感を形成する要因と
しては、血糖値の低下、血中遊離脂肪酸やケトン体の上
昇などがある。また、胃に対する機械的伸展刺激が、空
腹感を軽減することも古くから経験的に知られている。
Therefore, the basis of its prevention and treatment is to reduce calorie intake, that is, to implement a diet regimen. The biggest obstacle in implementing reduced eating therapy is that it is difficult to continue it due to strong feelings of hunger. Factors that create a feeling of hunger include a decrease in blood sugar levels and an increase in blood free fatty acids and ketone bodies. It has also been empirically known for a long time that mechanical stretching stimulation of the stomach reduces hunger.

これを利用して空腹感を軽減する目的でカロリーが低く
、かさの多い食物繊維を食品に配合するなどの工夫がな
されてきた。食物繊維によって持続的に空腹感を軽減す
るためには、食物繊維が長時間胃内に滞留することが必
要である。食物繊維の胃内滞留時間は、その粘度と相関
が高いと言われている。従って、空腹感の軽減効果を高
めるためには、より高粘度の食品を摂取する必要があり
、嗜”好上の困難があった。
To take advantage of this, efforts have been made to incorporate low-calorie, high-bulk dietary fiber into foods to reduce hunger. In order for dietary fiber to continuously reduce hunger, it is necessary for dietary fiber to remain in the stomach for a long time. It is said that the residence time of dietary fiber in the stomach is highly correlated with its viscosity. Therefore, in order to enhance the effect of reducing hunger, it is necessary to ingest foods with higher viscosity, which poses problems in terms of taste.

また、昨今の研究から食物繊維には脂質代謝改善作用や
耐糖能改善作用があることも報告されている。耐糖能改
善作用もまた空腹感の軽減作用と同様、粘度と相関が高
いと言われている。一方、食物繊維の大量摂取には、ミ
ネラルやビタミンなどの微量栄養素の吸収阻害などの負
の効果が懸念されている。従って、いかに少量の食物繊
維で空腹感の軽減や耐糖能改善作用を発現させるかが最
大の課題である。このような考えに基づいた提案がなさ
れている(特開昭63−185339)。
Furthermore, recent research has reported that dietary fiber has lipid metabolism-improving effects and glucose tolerance-improving effects. The glucose tolerance-improving effect is also said to be highly correlated with viscosity, as is the hunger-reducing effect. On the other hand, there are concerns that consuming large amounts of dietary fiber may have negative effects such as inhibiting the absorption of micronutrients such as minerals and vitamins. Therefore, the biggest challenge is how to reduce hunger and improve glucose tolerance with a small amount of dietary fiber. A proposal has been made based on this idea (Japanese Unexamined Patent Publication No. 185339/1983).

この発明は、カゼインとカラギナンなどの蛋白と反応性
を有する水溶性食物繊維を組合せ、この組成物がpHの
低下に伴いゲルを形成する特性を利用し、胃内でゲルを
形成させようとするものである。
This invention combines water-soluble dietary fibers that are reactive with proteins such as casein and carrageenan, and utilizes the property of this composition to form a gel as the pH decreases to form a gel in the stomach. It is something.

しかし、この組成物は粘度が温度に依存性の高い食物繊
維を用いているため、低温では粘度が高くなり、食感が
著しく損なわれる。そのため、この組成物はスープのご
とき高温で摂取される食品に用途が限定されていた。ま
た、カゼインが変性するような高温などの条件下でこの
組成物を含有する食品を加工することはできなかった。
However, since this composition uses dietary fiber whose viscosity is highly dependent on temperature, the viscosity increases at low temperatures and the texture is significantly impaired. Therefore, the use of this composition has been limited to foods that are consumed at high temperatures, such as soups. Also, it has not been possible to process foods containing this composition under conditions such as high temperatures that would denature the casein.

〔課題を解決するための手段〕[Means to solve the problem]

本発明の第1の目的は、胃内滞留時間が著しく長く、低
温でも食感が損なわれることなく、かつ嗜好性に優れ、
しかも摂取の不足が指摘されている食物繊維とカルシウ
ムを含有する肥満の治療または予防に使用される食品用
組成物を提供することにある。
The first object of the present invention is to have an extremely long gastric residence time, maintain its texture even at low temperatures, and have excellent palatability.
Moreover, it is an object of the present invention to provide a food composition that can be used to treat or prevent obesity and contains dietary fiber and calcium, which have been shown to be insufficient in intake.

本発明の第2の目的は、耐糖能が低下した者の血糖値の
急激な上昇を抑えインスリンの過剰分泌を抑制させる食
品用組成物を提供することにある。
A second object of the present invention is to provide a food composition that suppresses rapid increases in blood sugar levels in people with impaired glucose tolerance and suppresses excessive secretion of insulin.

かかる目的は下記の構成を有する本発明の食品用組成物
によって達成される。
This object is achieved by the food composition of the present invention having the following structure.

(1)水溶性食物繊維と中性領域で不溶性のカルシウム
化合物を含有する組成物からなり、該水溶性食物繊維と
該カルシウム化合物の水溶液が胃液と接触した際にゲル
状となるような割合であることを特徴とする食品用組成
物。
(1) A composition comprising water-soluble dietary fiber and an insoluble calcium compound in a neutral range, in a ratio such that an aqueous solution of the water-soluble dietary fiber and the calcium compound becomes gel-like when it comes into contact with gastric juice. A food composition characterized in that:

(2)水溶性食物繊維が、アルギン酸またはその塩であ
る請求項1記載の食品用組成物。
(2) The food composition according to claim 1, wherein the water-soluble dietary fiber is alginic acid or a salt thereof.

(3)  カルシウム化合物が炭酸カルシウム、第3燐
酸カルシウム、卵殻カルシウム、牛骨カルシウムおよび
魚骨カルシウムから選ばれた1種または2種以上の組合
せである請求項1記載の食品用組成物。
(3) The food composition according to claim 1, wherein the calcium compound is one or a combination of two or more selected from calcium carbonate, tertiary calcium phosphate, eggshell calcium, beef bone calcium, and fish bone calcium.

(4)水溶性食物繊維とカルシウム化合物中のカルシウ
ムとの重量比が1:0.1〜1:10である請求項1記
載の食品用組成物。
(4) The food composition according to claim 1, wherein the weight ratio of water-soluble dietary fiber to calcium in the calcium compound is 1:0.1 to 1:10.

(5)水溶性食物繊維とカルシウム化合物中のカルシウ
ムとの重量比がl:0.5〜1:2である請求項1記載
の食品用組成物。
(5) The food composition according to claim 1, wherein the weight ratio of water-soluble dietary fiber to calcium in the calcium compound is 1:0.5 to 1:2.

以下に本発明の食品用組成物について詳しく説明する。The food composition of the present invention will be explained in detail below.

水溶性食物繊維としては各種のものを使用できるが、ア
ルギン酸またはその塩、例えばアルギン酸ナトリウム、
アルギン酸カリウムなどが好適である。また、カルシウ
ム化合物としては炭酸カルシウム、第3燐酸カルシウム
、卵殻カルシウム。
Various types of water-soluble dietary fiber can be used, including alginic acid or its salts, such as sodium alginate,
Potassium alginate and the like are suitable. Calcium compounds include calcium carbonate, tertiary calcium phosphate, and eggshell calcium.

牛骨カルシウム、魚骨カルシウムなどが好ましいもので
あり、これらを単独で、もしくは2種以上を組合せて用
いる。これらのカルシウム化合物は中性領域では不溶性
もしくはほとんど溶解せず、従って、中性の溶液状で該
水溶性食物繊維と混合しても、この時点ではゲル化しな
い。さらに、水溶性食物繊維とカルシウム化合物中のカ
ルシウムとの重量比が1:0.1〜1:10である。カ
ルシウム化合物中のカルシウムの水溶性食物繊維に対す
る重量が0.01倍以下の場合には、胃酸によりカルシ
ウム化合物が全て溶解しても十分なゲル化は起こらない
。一方、カルシウム化合物中のカルシウムの水溶性食物
繊維に対する重量が8倍以上の場合にはカルシウム化合
物のざらつき惑が生じ、嗜好性が低下する。
Beef bone calcium, fish bone calcium, and the like are preferred, and these may be used alone or in combination of two or more. These calcium compounds are insoluble or barely soluble in a neutral region, and therefore, even when mixed with the water-soluble dietary fiber in the form of a neutral solution, they do not gel at this point. Furthermore, the weight ratio of water-soluble dietary fiber to calcium in the calcium compound is 1:0.1 to 1:10. If the weight of calcium in the calcium compound is less than 0.01 times the weight of water-soluble dietary fiber, sufficient gelation will not occur even if all the calcium compound is dissolved by stomach acid. On the other hand, when the weight of calcium in the calcium compound is 8 times or more relative to the water-soluble dietary fiber, the calcium compound becomes rough and confusing, resulting in decreased palatability.

また、本発明の食品用組成物は呈味性が低いので、本発
明の目的を逸脱しない範囲でいかなる食品にも配合する
ことができる。
Furthermore, since the food composition of the present invention has low taste, it can be incorporated into any food without departing from the purpose of the present invention.

〔実施例〕〔Example〕

次に、本発明の試験例および実施例を示すが、本発明は
これらにより制限されるものではない。
Next, test examples and examples of the present invention will be shown, but the present invention is not limited thereto.

試験例1 種々の水溶性食物繊維と種々のカルシウム化合物との混
合物の中性領域および酸性領域でのゲル形成について比
較した。すなわち、アルギン酸ナトリウム、カラギーナ
ン、ペクチン、アラビアガム、グアガム、カルボキシメ
チルセルロースおよびキサンタンガムについてそれぞれ
500■を計り取り蒸留水50111に溶解した後、I
NのNaOH溶液でp)lを7.0とし、さらに蒸留水
を加え100戚とした。この溶液を511!i!づつ試
験管に分取した。
Test Example 1 The gel formation of mixtures of various water-soluble dietary fibers and various calcium compounds in a neutral region and an acidic region was compared. That is, 500 ml of each of sodium alginate, carrageenan, pectin, gum arabic, guar gum, carboxymethyl cellulose and xanthan gum was weighed out and dissolved in 50111 of distilled water.
The p)l was adjusted to 7.0 with a NaOH solution of N, and distilled water was further added to adjust the p value to 100. This solution is 511! i! Aliquot them into test tubes.

この分取した溶液に塩化カルシウム、炭酸カルシウム、
クエン酸カルシウム、燐酸水素カルシウム。
Calcium chloride, calcium carbonate,
Calcium citrate, calcium hydrogen phosphate.

乳酸カルシウム、第3燐酸カルシウム、卵殻カルシウム
、牛骨カルシウムおよび魚骨カルシウムをカルシウムと
して25■となるよう添加し、溶解ないし懸濁した。こ
の時の溶液の性状を観察し、その結果を表1に示す。さ
らに、この溶液に1/IONの塩酸200μlを加えて
攪拌し、その性状を観察した。結果を表2に示す。表1
および表2に示すごとく、pH7,0では溶液の性状に
変化がなく、塩酸添加時にゲルを形成する組合せは、ア
ルギン酸ナトリウムまたはジェランガムと炭酸カルシウ
ム、第3燐酸カルシウム、卵殻カルシウム、牛骨カルシ
ウムまたは魚骨カルシウムの組合せのみであった。なお
、ペクチンもゲルを形成するが、このゲルは弱いもので
あった。また、第3燐酸カルシウムは牛骨カルシウムと
、炭酸カルシウムは卵殻カルシウムとほぼ同等の組成を
有し、本試験例においてもゲル形成に関して同様の作用
を示すことから、以下の実施例では水溶性食物繊維とし
てはアルギン酸ナトリウムおよびジェランガムを、カル
シウム化合物としては炭酸カルシウムおよび第3燐酸カ
ルシウムを使用することとした。
Calcium lactate, tertiary calcium phosphate, eggshell calcium, beef bone calcium and fish bone calcium were added to give a total calcium concentration of 25 μm and dissolved or suspended. The properties of the solution at this time were observed, and the results are shown in Table 1. Further, 200 μl of 1/ION hydrochloric acid was added to this solution, stirred, and its properties were observed. The results are shown in Table 2. Table 1
As shown in Table 2, there is no change in the properties of the solution at pH 7.0, and the combinations that form a gel when hydrochloric acid is added are sodium alginate or gellan gum and calcium carbonate, tribasic calcium phosphate, eggshell calcium, beef bone calcium, or fish. The only combination was bone calcium. Note that pectin also forms a gel, but this gel is weak. In addition, tertiary calcium phosphate has almost the same composition as beef bone calcium, and calcium carbonate has almost the same composition as eggshell calcium, and since they show similar effects regarding gel formation in this test example, water-soluble food Sodium alginate and gellan gum were used as the fibers, and calcium carbonate and tertiary calcium phosphate were used as the calcium compounds.

試験例2 アルギン酸ナトリウムまたはジェランガムと炭酸カルシ
ウムの混合物と先行技術であるカラギナンとカゼインナ
トリウムの混合物について粘度の温度依存性を比較した
。すなわち、5o!Idl容のビーカーを3個用意し、
その1つにはアルギン酸ナトリウム250■と炭酸カル
シウム250■を、2個目にはジェランガム250■と
炭酸カルシウム250■を、残る1つにはカラギナン2
50■とカゼインナトリウム125■をそれぞれ計り取
り蒸留水を加え、60°Cの恒温槽内で加温しながら溶
解し50mとした。この3種類の溶液につぃて60°C
150°C940°C130°C225°C(室温)、
20°c、iooCおよび4°C(冷蔵温度)の各温度
における粘度を測定した。粘度の測定はB型回転粘度計
(東京計器製造所■製)を用いて行った。結果は第1図
に示すごとく、アルギン酸ナトリウムと炭酸カルシウム
の溶液では温度低下に伴う粘度の上昇はほとんど見られ
ず、摂取も容易であった。
Test Example 2 The temperature dependence of viscosity was compared between a mixture of sodium alginate or gellan gum and calcium carbonate and a prior art mixture of carrageenan and sodium caseinate. In other words, 5o! Prepare three beakers of Idl capacity,
One of them contains 250μ of sodium alginate and 250μ of calcium carbonate, the second contains 250μ of gellan gum and 250μ of calcium carbonate, and the remaining one contains 250μ of carrageenan.
50 μm and 125 μm of sodium caseinate were weighed out, distilled water was added, and dissolved while heating in a constant temperature bath at 60° C. to make 50 μm. 60°C for these three solutions
150°C940°C130°C225°C (room temperature),
The viscosity was measured at 20°C, iooC and 4°C (refrigeration temperature). The viscosity was measured using a B-type rotational viscometer (manufactured by Tokyo Keiki Seisakusho ■). The results are shown in Figure 1, with the solution of sodium alginate and calcium carbonate, there was almost no increase in viscosity associated with a decrease in temperature, and it was easy to ingest.

実施例1 100all!容のメスフラスコを3本用意し、1木目
にはアルギン酸ナトリウム500■、炭酸カルシウム5
00■およびグルコース10gをメスフラスコに取り蒸
留水を加えて溶解し、100dとした。2木目には、ア
ルギン酸ナトリウム500■およびグルコース10gを
メスフラスコに取り蒸留水を加えて溶解し、100Id
とした。3本口には、グルコース10gをメスフラスコ
に取り蒸留水を加えて溶解し、100dとした。この3
種類の試料の胃内滞留時間を比較すべくラットに投与し
た。ラットはSD系雄性、体重的200gのものを1群
6個体とし、計18個体用いた。
Example 1 100all! Prepare three volumetric flasks with a volume of 500 μm and 500 μm of sodium alginate and 5 μm of calcium carbonate in the first grain.
00■ and 10 g of glucose were placed in a volumetric flask and distilled water was added to dissolve them to make 100 d. For the second grain, take 500 Id of sodium alginate and 10 g of glucose into a volumetric flask and add distilled water to dissolve them.
And so. For the third bottle, 10 g of glucose was placed in a volumetric flask and distilled water was added to dissolve it to make 100 d. This 3
Different types of samples were administered to rats in order to compare their retention times in the stomach. A total of 18 SD male rats, 6 rats per group, weighing 200 g were used.

まず、ラットを24時間絶食させ、上記3種類の試料を
体重100g当りldの割合で胃ゾンデにて強制投与し
た。投与30分後、断頭層殺し、腹部を切開して胃の幽
門部および食道をクレンメで閉塞後、胃を摘出した。摘
出した胃の内容物を最終量が10dとなるように蒸留水
で洗い込み試験管に取った。この溶液を300Orpm
で10分間遠心分離し、得られた上清をムタロターゼ・
GOD法でグルコース量を測定し、各試料の胃内残存率
を求めた。結果を第2図に示す。第2図に示されるごと
く、アルギン酸ナトリウム0.5%、炭酸カルシウム0
.5%およびグルコース10%を投与した群は、他の2
群に比して有意に高い残存率を示した。また、アルギン
酸ナトリウム0.5%。
First, rats were fasted for 24 hours, and the three types of samples mentioned above were forcibly administered at a rate of 1 d/100 g of body weight using a gastric tube. Thirty minutes after administration, the animal was decapitated, the abdomen was incised, the pylorus of the stomach and the esophagus were obstructed with a cleanser, and the stomach was removed. The contents of the excised stomach were washed with distilled water to a final volume of 10 d and taken into a test tube. This solution was heated to 300 rpm.
Centrifuge for 10 minutes at
The amount of glucose was measured by the GOD method, and the residual rate in the stomach of each sample was determined. The results are shown in Figure 2. As shown in Figure 2, sodium alginate 0.5%, calcium carbonate 0
.. The groups administered 5% and 10% glucose were
The survival rate was significantly higher than that of the other groups. Also, sodium alginate 0.5%.

炭酸カルシウム0.5%およびグルコース10%を投与
した群は、投与した試料が胃内で透明なゲルを形成して
いた。
In the group to which 0.5% calcium carbonate and 10% glucose were administered, the administered sample formed a transparent gel in the stomach.

実施例2 10011j!容のメスフラスコを2本用意し、1木目
にはアルギン酸ナトリウム500■、第3燐酸カルシウ
ム500■およびグルコース10gをメスフラスコに取
り蒸留水を加えて溶解し、100dとした。2木目には
、アルギン酸ナトリウム500■およびグルコース10
gをメスフラスコに取り蒸留水を加え溶解し100−と
じた。この2種類の試料の耐糖能改善効果を比較すべく
ラットに投与した。ラットはSD系雄性、体重的200
gのものを1群6個体とし、計12個体用いた。
Example 2 10011j! Two volumetric flasks were prepared, and in the first grain, 500 μm of sodium alginate, 500 μm of tertiary calcium phosphate, and 10 g of glucose were placed in the volumetric flasks and distilled water was added to dissolve them to give a total volume of 100 μm. For the second grain, sodium alginate 500■ and glucose 10
g was taken into a volumetric flask, distilled water was added to dissolve it, and the mixture was sealed at 100%. These two types of samples were administered to rats in order to compare their effects on improving glucose tolerance. The rat is an SD male, weight 200.
A total of 12 individuals were used, with 6 individuals per group.

まず、ラットを24時間絶食させ、上記2種類の試料を
体重100g当り1dの割合で胃ゾンデにて強制投与し
た。投与前、投与15分後、投与30分後および投与6
0分後の各時点で尾静脈より血液30μlを採血し、直
ちにグルコースオキシダーゼ法で血糖値を測定した。結
果を第3図に示す。第3図に示されるごとく、アルギン
酸ナトリウム0.5%、第3燐酸カルシウム0.5%お
よびグルコース10%を投与した群は、アルギン酸ナト
リウム0゜5%、およびグルコース10%を投与した群
に比して、投与15分後の血糖値は低値を示し、投与6
0分後ではやや高値を示した。
First, rats were fasted for 24 hours, and the two types of samples mentioned above were forcibly administered at a rate of 1 d per 100 g of body weight using a gastric tube. Before administration, 15 minutes after administration, 30 minutes after administration and administration 6
At each time point after 0 minutes, 30 μl of blood was collected from the tail vein, and the blood sugar level was immediately measured using the glucose oxidase method. The results are shown in Figure 3. As shown in Figure 3, the group administered with 0.5% sodium alginate, 0.5% tertiary calcium phosphate and 10% glucose was compared to the group administered with 0.5% sodium alginate and 10% glucose. 15 minutes after administration, the blood sugar level showed a low value.
After 0 minutes, the value was slightly high.

従って、アルギン酸ナトリウム0.5%、第3燐酸カル
シウム0.5%およびグルコース10%を投与した群は
急激な血糖値の上昇を抑え、ゆっくりと糖の吸収を行わ
せる、即ち耐糖能を改善する効果が認められた。
Therefore, the group administered with 0.5% sodium alginate, 0.5% tribasic calcium phosphate, and 10% glucose suppressed the rapid rise in blood sugar level and allowed sugar absorption to occur slowly, that is, to improve glucose tolerance. The effect was recognized.

実施例3 100jd!容のメスフラスコを3本用意し、1木目に
はアルギン酸ナトリウム500■および炭酸カルシウム
500■をメスフラスコに取り蒸留水を加えて溶解し、
100dとした。2木目には、アルギン酸ナトリウム5
00■をメスフラスコに取り蒸留水を加えて溶解し、1
00dとした。また、3本口には、アルギン酸ナトリウ
ム500■をメスフラスコに取り蒸留水を加えて溶解し
、100dとしたのち、この溶液を100−容ビーカー
に移し、塩化カルシウム500■を加えゲルを形成させ
た。このゲルをミキサーで破砕し、被検液とした。この
3種類の試料の耐糖能改善効果を比較較すべくラットに
投与した。ラットはSD系雄性、体重的200gのもの
を1群6個体とし、計24個体用いた。
Example 3 100jd! Prepare 3 volumetric flasks, put 500 μm of sodium alginate and 500 μm of calcium carbonate into the volumetric flask and add distilled water to dissolve them.
It was set to 100d. On the second grain, sodium alginate 5
Take 00■ in a volumetric flask and add distilled water to dissolve it.
It was set to 00d. In addition, for the third neck, take 500 µm of sodium alginate in a volumetric flask, add distilled water to dissolve it to make 100 d, then transfer this solution to a 100-capacity beaker, add 500 µm of calcium chloride, and form a gel. Ta. This gel was crushed with a mixer and used as a test solution. These three types of samples were administered to rats in order to compare their effects on improving glucose tolerance. A total of 24 SD male rats, 6 rats per group, weighing 200 g were used.

まず、ラットにストレプトシトシンを体重100g当り
55■の割合で尾静脈より注射して、糖尿病モデルラッ
トを作製し、2週間後実験に供した。
First, streptocytosine was injected into rats through the tail vein at a rate of 55 μg per 100 g of body weight to prepare diabetic model rats, and 2 weeks later they were used for experiments.

ラットを24時間絶食させ、上記3種類の試料を体重1
00g当りll11の割合で胃ゾンデにて強制投与し、
その直後に10%グルコース溶液1dを胃ゾンデにて強
制投与した。また、対照群には蒸留水を体重100g当
りll11の割合で胃ゾンデにて強制投与し、その直後
に10%グルコース溶液IIdを胃ゾンデにて強制投与
した。投与前、投与15分後、投与30分後、投与60
分後および投与120分後の各時点で尾静脈より血液3
0mを採血し、直ちにグルコースオキシダーゼ法で血糖
値を測定した。結果を第4図に示す。第4図に示される
ごとく、アルギン酸ナトリウム0.5%。
Rats were fasted for 24 hours, and the above three types of samples were added to the body weight of 1
Forcibly administered with a gastric tube at a rate of 11/00g,
Immediately thereafter, 1 d of 10% glucose solution was forcibly administered using a stomach tube. In addition, to the control group, distilled water was forcibly administered at a rate of 11 l/100 g of body weight using a stomach probe, and immediately thereafter, a 10% glucose solution IId was forcibly administered using a stomach probe. Before administration, 15 minutes after administration, 30 minutes after administration, 60 minutes after administration
Blood was collected from the tail vein at each time point 3 min and 120 min after administration.
Blood was collected at 0 m, and the blood sugar level was immediately measured using the glucose oxidase method. The results are shown in Figure 4. As shown in Figure 4, sodium alginate 0.5%.

炭酸カルシウム0.5%およびグルコース10%を投与
した群では他の3群に比して、投与15分後の血糖値は
低値を示し、投与60分後ではやや高値を示した。この
ような糖尿病ラットにおいてもアルギン酸ナトリウム0
.5%、炭酸カルシウム0.5%およびグルコース10
%を投与した群では他の2群に比して、急激な血糖値の
上昇を抑えゆっくりと糖の吸収を行わせる、即ち、耐糖
能を改善する効果が認められた。
In the group to which 0.5% calcium carbonate and 10% glucose were administered, the blood sugar level showed a lower value 15 minutes after administration, and a slightly higher value 60 minutes after administration, compared to the other three groups. Even in such diabetic rats, sodium alginate 0
.. 5%, calcium carbonate 0.5% and glucose 10
Compared to the other two groups, the group administered % of the drug was found to have the effect of suppressing the rapid rise in blood sugar levels and slowing down sugar absorption, that is, improving glucose tolerance.

〔発明の効果〕〔Effect of the invention〕

以上詳述したごとく、 本発明の食品用組成物は、 水溶性食物繊維と中性領域で不溶性のカルシウム化合物
を含有することにより、摂取後胃内で胃酸と接触した際
ゲルを、形成する。食物の胃内滞留時間は、成分によっ
ても異なるが、食物繊維においてはその粘度が高いほど
胃内滞留時間は長くなる。
As detailed above, the food composition of the present invention contains water-soluble dietary fiber and a calcium compound that is insoluble in the neutral region, so that it forms a gel when it comes into contact with gastric acid in the stomach after ingestion. The residence time of food in the stomach varies depending on the ingredients, but the higher the viscosity of dietary fiber, the longer the residence time in the stomach.

従って、本発明の食品用組成物を摂取すれば、摂取時は
低温でも粘度が低く嗜好性に優れている上に胃内ではゲ
ル化し、胃内に長時間滞留するため、効果的に食欲を抑
制することができる。しかも、糖の吸収を遅延させるた
め、耐糖能をも改善する。
Therefore, if the food composition of the present invention is ingested, it has a low viscosity and good palatability even at low temperatures, and also gels in the stomach and remains there for a long time, effectively suppressing appetite. Can be suppressed. Moreover, it also improves glucose tolerance by delaying sugar absorption.

さらには、本食品用組成物を摂取することにより、最近
摂取の不足が指摘されている食物繊維とカルシウムの栄
養的な補給も同時に行うことができる。
Furthermore, by ingesting this food composition, it is possible to simultaneously provide nutritional supplementation of dietary fiber and calcium, which have recently been pointed out to be insufficient in intake.

また、カルシウムの吸収を促進することが知られている
カゼインホスホペプチドと組み合せることも容易であり
、さらにカルシウムの栄養的な補給効果を高めることが
できる。また、本発明の食品用組成物は食品の加工時に
pHが3.5以下にならないような工程を選べば、水溶
性食物繊維と中性領域で不溶性のカルシウム化合物の反
応が生じないため、液状、粉状、固形状などあらゆる食
品の形態を選択することかでき、かつ水溶性食物繊維と
中性領域で不溶性のカルシウム化合物はいずれも無味無
臭に近いため、様々な味付けか可能であり、本発明の食
品用組成物を継続的に摂取する場合、極めて好都合であ
る。
Furthermore, it can be easily combined with casein phosphopeptide, which is known to promote calcium absorption, and can further enhance the nutritional supplementation effect of calcium. In addition, if the food composition of the present invention is selected in a process that does not cause the pH to fall below 3.5 during food processing, the reaction between the water-soluble dietary fiber and the insoluble calcium compound in the neutral region will not occur. You can choose any food form, such as powder, solid, etc., and since both water-soluble dietary fiber and insoluble calcium compounds in the neutral range are almost tasteless and odorless, various flavorings are possible. It is extremely advantageous if the food composition of the invention is taken continuously.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は各種食物繊維含有組成物溶液の温度−粘度相関
図、第2図は動物実験における投与30分後の胃内のグ
ルコースの残存量を示す図、第3図は正常なラットを用
いた試験における血糖値(ラット6匹の平均値)の変化
を示す図、第4図は糖尿病ラットを用いた試験における
血糖値(ラット6匹の平均値)の変化を示す図である。 殿巳 拓 図 (本会9男) 憩 凹 蔚 間 ト偏0 第 図 時 開 障ノ
Figure 1 is a temperature-viscosity correlation diagram of various dietary fiber-containing composition solutions, Figure 2 is a diagram showing the residual amount of glucose in the stomach 30 minutes after administration in animal experiments, and Figure 3 is a diagram showing the amount of glucose remaining in the stomach 30 minutes after administration in animal experiments. Figure 4 is a diagram showing changes in blood sugar levels (average value of 6 rats) in a test using diabetic rats. Takuzu Tonomi (9th son of the Society) Ikuko Urugma Tobias 0 Diagram Time Opening Obstruction

Claims (5)

【特許請求の範囲】[Claims] (1)水溶性食物繊維と中性領域で不溶性のカルシウム
化合物を含有する組成物からなり、該水溶性食物繊維と
該カルシウム化合物の水溶液が胃液と接触した際にゲル
状となるような割合であることを特徴とする食品用組成
物。
(1) A composition comprising water-soluble dietary fiber and an insoluble calcium compound in a neutral range, in a ratio such that an aqueous solution of the water-soluble dietary fiber and the calcium compound becomes gel-like when it comes into contact with gastric juice. A food composition characterized in that:
(2)水溶性食物繊維が、アルギン酸またはその塩であ
る請求項1記載の食品用組成物。
(2) The food composition according to claim 1, wherein the water-soluble dietary fiber is alginic acid or a salt thereof.
(3)カルシウム化合物が炭酸カルシウム、第3燐酸カ
ルシウム、卵殻カルシウム、牛骨カルシウムおよび魚骨
カルシウムから選ばれた1種または2種以上の組合せで
ある請求項1記載の食品用組成物。
(3) The food composition according to claim 1, wherein the calcium compound is one or a combination of two or more selected from calcium carbonate, tertiary calcium phosphate, eggshell calcium, beef bone calcium, and fish bone calcium.
(4)水溶性食物繊維とカルシウム化合物中のカルシウ
ムとの重量比が1:0.1〜1:10である請求項1記
載の食品用組成物。
(4) The food composition according to claim 1, wherein the weight ratio of water-soluble dietary fiber to calcium in the calcium compound is 1:0.1 to 1:10.
(5)水溶性食物繊維とカルシウム化合物中のカルシウ
ムとの重量比が1:0.5〜1:2である請求項1記載
の食品用組成物。
(5) The food composition according to claim 1, wherein the weight ratio of water-soluble dietary fiber to calcium in the calcium compound is 1:0.5 to 1:2.
JP2125544A 1990-05-17 1990-05-17 Food composition Expired - Lifetime JP2673992B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2125544A JP2673992B2 (en) 1990-05-17 1990-05-17 Food composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2125544A JP2673992B2 (en) 1990-05-17 1990-05-17 Food composition

Publications (2)

Publication Number Publication Date
JPH0423968A true JPH0423968A (en) 1992-01-28
JP2673992B2 JP2673992B2 (en) 1997-11-05

Family

ID=14912827

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2125544A Expired - Lifetime JP2673992B2 (en) 1990-05-17 1990-05-17 Food composition

Country Status (1)

Country Link
JP (1) JP2673992B2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002017734A3 (en) * 2000-09-01 2003-04-24 Univ Tennessee Res Corp Materials and methods for the treatment or prevention of obesity
JP2004002320A (en) * 2002-03-04 2004-01-08 Medorekkusu:Kk Liquid matrix causing in-vivo phase transition and liquid oral preparation
EP1395128A2 (en) 2001-05-31 2004-03-10 Abbott Laboratories Acid controlled viscosity fibre system and uses thereof
WO2005020719A1 (en) * 2003-09-03 2005-03-10 Unilever N.V. Satiety enhancing food compositions
WO2005020718A1 (en) * 2003-09-03 2005-03-10 Unilever N.V. Satiety enhancing food compositions
US7704979B2 (en) 2000-09-01 2010-04-27 The University Of Tennessee Research Foundation Materials and methods for the treatment or prevention of obesity
JP2014000054A (en) * 2012-06-20 2014-01-09 Shimadaya Corp Wheat noodle for preventing rise of blood glucose level after ingestion
US8889617B2 (en) 2009-12-18 2014-11-18 Kaneka Corporation Liquid food composition
JP2015089357A (en) * 2013-11-06 2015-05-11 ユニテックフーズ株式会社 New gelatinizer
US9192573B2 (en) 2009-12-18 2015-11-24 Kaneka Corporation Treatment method using liquid food composition

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1931222T3 (en) * 2005-10-05 2012-07-31 Technostics Ltd Gelling compositions and methods

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5774072A (en) * 1980-10-29 1982-05-10 Yamanouchi Pharmaceut Co Ltd Granule of dietary fiber and its preparation
JPS6348210A (en) * 1986-08-19 1988-02-29 Freunt Ind Co Ltd Easily soluble granule
JPS63185339A (en) * 1986-09-01 1988-07-30 Terumo Corp Composition for food

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5774072A (en) * 1980-10-29 1982-05-10 Yamanouchi Pharmaceut Co Ltd Granule of dietary fiber and its preparation
JPS6348210A (en) * 1986-08-19 1988-02-29 Freunt Ind Co Ltd Easily soluble granule
JPS63185339A (en) * 1986-09-01 1988-07-30 Terumo Corp Composition for food

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001288707B9 (en) * 2000-09-01 2007-08-30 University Of Tennessee Research Foundation Materials and methods for the treatment or prevention of obesity
WO2002017734A3 (en) * 2000-09-01 2003-04-24 Univ Tennessee Res Corp Materials and methods for the treatment or prevention of obesity
US7704979B2 (en) 2000-09-01 2010-04-27 The University Of Tennessee Research Foundation Materials and methods for the treatment or prevention of obesity
AU2001288707C1 (en) * 2000-09-01 2008-05-29 University Of Tennessee Research Foundation Materials and methods for the treatment or prevention of obesity
US8541392B2 (en) 2001-05-31 2013-09-24 Abbott Laboratories Polymer controlled induced viscosity fiber system and uses thereof
EP1395128A2 (en) 2001-05-31 2004-03-10 Abbott Laboratories Acid controlled viscosity fibre system and uses thereof
EP1395128B2 (en) 2001-05-31 2011-07-13 Abbott Laboratories Acid controlled viscosity fibre system and uses thereof
JP2004002320A (en) * 2002-03-04 2004-01-08 Medorekkusu:Kk Liquid matrix causing in-vivo phase transition and liquid oral preparation
WO2005020718A1 (en) * 2003-09-03 2005-03-10 Unilever N.V. Satiety enhancing food compositions
WO2005020719A1 (en) * 2003-09-03 2005-03-10 Unilever N.V. Satiety enhancing food compositions
US8889617B2 (en) 2009-12-18 2014-11-18 Kaneka Corporation Liquid food composition
US9192573B2 (en) 2009-12-18 2015-11-24 Kaneka Corporation Treatment method using liquid food composition
EP3461473A1 (en) 2009-12-18 2019-04-03 Kaneka Corporation Liquid food composition being semisolidified in the acidic region
JP2014000054A (en) * 2012-06-20 2014-01-09 Shimadaya Corp Wheat noodle for preventing rise of blood glucose level after ingestion
JP2015089357A (en) * 2013-11-06 2015-05-11 ユニテックフーズ株式会社 New gelatinizer

Also Published As

Publication number Publication date
JP2673992B2 (en) 1997-11-05

Similar Documents

Publication Publication Date Title
CN101925307B (en) High energy liquid enteral nutritional composition
JP2599400B2 (en) Formulated liquid nutritional composition for glucose intolerant patients
WO2008066308A1 (en) Food composition for increasing the satiety and satiation
CN104642839B (en) A kind of health-care fish oil jelly and preparation method thereof
WO2021104155A1 (en) Hydrogel tablet for dispelling effect of alcohol and protecting liver, and preparation method therefor and use thereof
WO1988001477A1 (en) Food composition
JPH0423968A (en) Composition for food
JPS63287462A (en) Peptide nutrient agent
JP2002034592A (en) Method for producing protein-zinc readily absorbable in body
EP0075594A1 (en) Glucose polymers and method of producing same
JP3720496B2 (en) Novel pectin and emulsion containing the same
JP5383244B2 (en) Nutritional agent suitable for improving symptoms or nutritional status of cancer patients
JPH11332514A (en) Balanced nutritive food
CN111406935A (en) Carbohydrate component formula food suitable for preoperative taking and having special medical application and application thereof
JP2000050819A (en) Rice gruel
JPH0621077B2 (en) Hematopoietic agent
CN115067504B (en) Special medical food for intestinal tract preparation and preparation method thereof
JP2986324B2 (en) Diet / Diabetic Food
EP1037539A1 (en) Method for accelerating protein digestion rate
JP2000189109A (en) Liquid food
JP2002142720A (en) Nutritional composition
JP3165743B2 (en) Liquid food
JP3336340B2 (en) Rice treated with artificial digestive enzyme and its production method
JP2900070B2 (en) Potassium supplement composition for food and method for producing the same
JP2017160177A (en) Slurry nutritional composition

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090718

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100718

Year of fee payment: 13

EXPY Cancellation because of completion of term